These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3937252)

  • 1. [Circulating anticoagulants against coagulation factors with special reference to anti-factor VIII:C].
    Aznar JA
    Sangre (Barc); 1985; 30(4-C):813-8. PubMed ID: 3937252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
    Windyga J; Rzymkiewicz L; Lopaciuk S
    Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
    Ambriz-Fernández R; Reyna-Fregoso MP; Pizzuto-Chávez J; Rodríguez-Moyado H; Farfán-Canto JM; Trueba-Christy E; Collazo-Jaloma J
    Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-factor VIII antibodies in children with hemophilia, and the management of hemorrhage].
    Klukowska A; Adamowicz-Salach A; Kamińska D; Zieleniewska B
    Pol Tyg Lek; 1987 Jul; 42(30):911-4. PubMed ID: 3118341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibitors (antibodies) directed against factor VIII in hemophilia A (author's transl)].
    Beck EA
    Ther Umsch; 1979 Apr; 36(4):326-9. PubMed ID: 377556
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor].
    Turkstra F; Levi M; Koopman MM; Wester JP; Stoutenbeek CP; Briët E
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1464-7. PubMed ID: 9752060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating anticoagulants in hemophilia A].
    Michalski R; Lopaciuk S
    Acta Haematol Pol; 1973; 4(3):203-9. PubMed ID: 4800573
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulating anticoagulants in hemophilia].
    Josso F; Cosson A; Gazengel C; Allain JP
    Rev Fr Transfus; 1972 Sep; 15(3):281-98. PubMed ID: 4657669
    [No Abstract]   [Full Text] [Related]  

  • 11. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
    Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies].
    Gassmann AE; Kerkhofs H; Leeksma CH
    Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acquired autoantibodies against human factor VIII: a new case].
    Cailleux N; Levesque H; Courtois H; Borg JY
    J Mal Vasc; 1996; 21(5):324-8. PubMed ID: 9026552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of naturally occurring antibodies to factor VIII on an immunoradiometric assay for factor VIII coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIII inhibit.
    Brown JE; Carton CL; Hougie C
    J Lab Clin Med; 1981 Jan; 97(1):65-71. PubMed ID: 6778942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Yee TT; Lee CA
    Thromb Haemost; 1999 May; 81(5):852. PubMed ID: 10365768
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of coagulation factor VIII inhibitors].
    Lutze G; Schlote A; Mittler U
    Z Gesamte Inn Med; 1980 Apr; 35(8):330-6. PubMed ID: 6776700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies.
    Leggett PL; Doyle D; Smith WB; Culpepper W; Cooper S; Ochsner JL
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):556-60. PubMed ID: 6423912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR and Factor VIII antibodies in hemophilia A.
    Mayr WR; Lechner K; Niessner H; Pabinger-Fasching I
    Thromb Haemost; 1984 Apr; 51(2):293. PubMed ID: 6429887
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of phospholipid on factor VIII inactivation.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    Prog Clin Biol Res; 1984; 150():251-63. PubMed ID: 6431431
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.
    Pascual V; Capra JD
    J Clin Invest; 1996 Mar; 97(6):1357-8. PubMed ID: 8617864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.